Rhumbline Advisers Sqz Biotechnologies CO Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$2.77 - $5.0 $69,659 - $125,740
-25,148 Closed
0 $0
Q1 2022

May 12, 2022
SELL
$4.01 - $10.42 $5,353 - $13,910
-1,335 Reduced 5.04%
25,148 $121,000
Q4 2021

Feb 10, 2022
SELL
$8.93 - $14.85 $3,598 - $5,984
-403 Reduced 1.5%
26,483 $236,000
Q3 2021

Nov 12, 2021
BUY
$11.46 - $15.77 $12,033 - $16,558
1,050 Added 4.06%
26,886 $388,000
Q2 2021

Aug 05, 2021
BUY
$11.32 - $14.45 $292,463 - $373,330
25,836 New
25,836 $373,000

Others Institutions Holding SQZ

# of Institutions
3
Shares Held
1.47M
Call Options Held
0
Put Options Held
0
View Full List

About SQZ Biotechnologies Co

SQZ Quotes by TradingView
  • Ticker SQZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,248,600
  • Market Cap $1.46M
  • Description
  • SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...
More about SQZ
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email